Three-year follow-up of [CA-125, CA 19-9, CA 15-3, SIL-2R, IL-6, IL-la, TNF-a, sCD8 and sCD4] levels in a woman with severe endometriosis

Eur J Obstet Gynecol Reprod Biol. 2000 Dec;93(2):127-9. doi: 10.1016/s0301-2115(00)00245-1.

Abstract

A 37-year old woman presented with severe endometriosis and the patient underwent a conservative operation. We investigated the effect of treatment with danazol on the levels of CA-125, CA-19-9, CA 15-3, SIL-2R, IL-6, IL-1a, TNE-a, SCD8 and SCD4 in this woman. Our findings suggest that severe endometriosis is a condition which induces a rise of tumor markers and cytokine levels that are suppressed on danazol treatment.

MeSH terms

  • Adult
  • Biomarkers, Tumor / blood*
  • CA-125 Antigen / blood
  • CA-19-9 Antigen / blood
  • CD4 Antigens / blood
  • CD8 Antigens / blood
  • Cytokines / blood*
  • Danazol / therapeutic use*
  • Endometriosis / blood
  • Endometriosis / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin-1 / blood
  • Interleukin-6 / blood
  • Mucin-1 / blood
  • Receptors, Interleukin-2 / analysis
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen
  • CA-19-9 Antigen
  • CD4 Antigens
  • CD8 Antigens
  • Cytokines
  • Interleukin-1
  • Interleukin-6
  • Mucin-1
  • Receptors, Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Danazol